These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 3404360

  • 21. Comparative in vitro and in vivo studies of enteric-coated pancrelipase preparations for pancreatic insufficiency.
    Thomson M, Clague A, Cleghorn GJ, Shepherd RW.
    J Pediatr Gastroenterol Nutr; 1993 Nov; 17(4):407-13. PubMed ID: 8145097
    [Abstract] [Full Text] [Related]

  • 22. Ranitidine and omeprazole as adjuvant therapy to pancrelipase to improve fat absorption in patients with cystic fibrosis.
    Francisco MP, Wagner MH, Sherman JM, Theriaque D, Bowser E, Novak DA.
    J Pediatr Gastroenterol Nutr; 2002 Jul; 35(1):79-83. PubMed ID: 12142815
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pancreatic enzyme supplement dosage in cystic fibrosis.
    Owen G, Peters TJ, Dawson S, Goodchild MC.
    Lancet; 1991 Nov 02; 338(8775):1153. PubMed ID: 1682579
    [No Abstract] [Full Text] [Related]

  • 25. Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2-antagonists, and enteric coating.
    Marotta F, O'Keefe SJ, Marks IN, Girdwood A, Young G.
    Dig Dis Sci; 1989 Mar 02; 34(3):456-61. PubMed ID: 2563963
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy.
    Pettei MJ, Leonidas JC, Levine JJ, Gorvoy JD.
    J Pediatr; 1994 Oct 02; 125(4):587-9. PubMed ID: 7931879
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis.
    Santini B, Antonelli M, Battistini A, Bertasi S, Collura M, Esposito I, Di Febbraro L, Ferrari R, Ferrero L, Iapichino L, Lucidi V, Manca A, Pisconti CL, Pisi G, Raia V, Romano L, Rosati P, Grazioli I, Melzi G.
    Dig Liver Dis; 2000 Oct 02; 32(5):406-11. PubMed ID: 11030186
    [Abstract] [Full Text] [Related]

  • 38. Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency.
    Zerega J, Lerner S, Meyer JH.
    Dig Dis Sci; 1988 Oct 02; 33(10):1245-9. PubMed ID: 3168697
    [Abstract] [Full Text] [Related]

  • 39. Correction of malnutrition and maldigestion with enzyme supplementation in patients with surgical suppression of exocrine pancreatic function.
    Braga M, Cristallo M, De Franchis R, Mangiagalli A, Agape D, Primignani M, Di Carlo V.
    Surg Gynecol Obstet; 1988 Dec 02; 167(6):485-92. PubMed ID: 3187872
    [Abstract] [Full Text] [Related]

  • 40. Treatment failure after substitution of generic pancrelipase capsules.
    Haymes AJ, Levy RA.
    JAMA; 1990 Dec 26; 264(24):3148-9. PubMed ID: 2255022
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.